There are 859 resources available
Q&A and discussion
Presenter: All Speakers
Session: Treatment optimisation in early triple negative breast cancer (TNBC)
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Proffered Paper session: Thoracic cancer
Resources:
Webcast
405MO - Pan-cancer analysis of 4-1BB transcriptome expression and its impact on outcome in patients treated with immune checkpoint inhibitors
Presenter: Yuji Uehara
Session: Mixed Proffered paper and Mini oral session: Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
LBA12 - Efficacy and safety of IBI351 (GFH925), a selective KRASG12C inhibitor, monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Initial results from a registrational phase II study
Presenter: Jiaxin Lin
Session: Proffered Paper session: Thoracic cancer
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Implication of lymphoma classification in 2023
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mixed Proffered paper and Mini oral session: Gynaecological cancers
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: An eye on the future: Promising agents from early drug development in gastrointestinal tumours
Resources:
Webcast
288MO - InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer
Presenter: Keiichi Fujiwara
Session: Mixed Proffered paper and Mini oral session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA12
Presenter: Jordi Remon Masip
Session: Proffered Paper session: Thoracic cancer
Resources:
Slides
Webcast
Invited Discussant 404MO and 405MO
Presenter: Aaron Hansen
Session: Mixed Proffered paper and Mini oral session: Developmental and precision medicine
Resources:
Slides
Webcast